Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Undisclosed
Sponsor : OnDosis
Deal Size : Undisclosed
Deal Type : Partnership
Camallergy and OnDosis Announce a Groundbreaking Partnership to Revolutionize Food Allergy Treatment
Details : Under the partnership, Camallergy's innovative therapies is combined with OnDosis' cutting-edge Dosage Manager device technology to address the challenges physicians face in offering oral immunotherapy.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
November 29, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Undisclosed
Sponsor : OnDosis
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?